{"id":9326,"date":"2025-12-09T14:12:50","date_gmt":"2025-12-09T11:12:50","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9326"},"modified":"2025-12-09T14:12:50","modified_gmt":"2025-12-09T11:12:50","slug":"multisociety-hypertension-guidelines-messages-to-the-world","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/multisociety-hypertension-guidelines-messages-to-the-world\/","title":{"rendered":"Multisociety Hypertension Guidelines (Messages to the World)"},"content":{"rendered":"
Multisociety Hypertension Guidelines (Messages to the World)<\/div>\n
<\/div>\n
Source: Hypertension News \u2013 December 2025<\/div>\n
<\/div>\n
Keynotes :<\/div>\n
\u20071.\u2060 \u2060Broad, Multidisciplinary U.S. Effort<\/div>\n
\u2022 Guideline developed with 11 U.S. societies (cardiology, nephrology, geriatrics, neurology, pharmacy, nursing, general practice).<\/span><\/div>\n
\u2022 Reflects a team-based, population-level strategy for a country where >45% of adults meet hypertension criteria.<\/span><\/div>\n
<\/div>\n
\u20072.\u2060 \u2060Blood Pressure Measurement & Diagnosis<\/div>\n
\u2022 Use validated automated office devices; avoid cuffless devices.<\/span><\/div>\n
\u2022 ABPM\/HBPM required in most patients for diagnosis and titration.<\/span><\/div>\n
\u2022 ABPM has stronger evidence, but HBPM is more practical and widely recommended.<\/span><\/div>\n
<\/div>\n
\u20073.\u2060 \u2060Screening for Primary Aldosteronism<\/div>\n
\u2022 Broader screening indications: resistant HTN, hypokalemia, sleep apnea, adrenal incidentaloma, early-onset HTN, stroke <40 yrs.<\/span><\/div>\n
\u2022 Screening can be done while continuing most antihypertensives (stop MRAs & beta-blockers).<\/span><\/div>\n
<\/div>\n
\u20074.\u2060 \u2060New Risk Assessment Model<\/div>\n
\u2022 Recommend AHA PREVENT\u2122\ufe0f to assess 10\u201330-year cardiovascular risk.<\/span><\/div>\n
\u2022 Includes kidney markers (UACR), HbA1c, BMI, and social deprivation index.<\/span><\/div>\n
<\/div>\n
\u20075.\u2060 \u2060When to Start Treatment<\/div>\n
\u2022 Start at >140\/90 mmHg for all adults.<\/span><\/div>\n
\u2022 Start at \u2265130\/80 mmHg if:<\/span><\/div>\n
\u2022 Diabetes<\/span><\/div>\n
\u2022 CKD<\/span><\/div>\n
\u2022 10-year CVD risk \u22657.5%<\/span><\/div>\n
\u2022 Lower-risk patients can try lifestyle first (3\u20136 months).<\/span><\/div>\n
<\/div>\n
\u20076.\u2060 \u2060BP Treatment Targets<\/div>\n
\u2022 Goal for nearly all adults = <130\/80 mmHg.<\/span><\/div>\n
\u2022 Encouragement to reach SBP <120 mmHg in many patients (Class IIb) \u2014 based on meta-analysis showing net CV benefit.<\/span><\/div>\n
\u2022 Opposes 2024 ESH guidance (which discourages <120 mmHg).<\/span><\/div>\n
<\/div>\n
\u20077.\u2060 \u2060Monotherapy vs Combination<\/div>\n
\u2022 Stage 1 (130\u2013139\/80\u201389): monotherapy reasonable.<\/span><\/div>\n
\u2022 Stage 2 (\u2265140\/90): start 2-drug combination, ideally a single-pill combo.<\/span><\/div>\n
<\/div>\n
\u20078.\u2060 \u2060Renal Denervation<\/div>\n
\u2022 Consider in:<\/span><\/div>\n
\u2022 Resistant HTN: \u2265140\/90 on \u22654 drugs (ACEi\/ARB + CCB + thiazide-type diuretic + MRA).<\/span><\/div>\n
\u2022 Uncontrolled HTN when optimal dosages cannot be used.<\/span><\/div>\n
\u2022 Growing global acceptance; requires referral to expert centers.<\/span><\/div>\n
<\/div>\n
\u20079.\u2060 \u2060Framework for Improving BP Control<\/div>\n
<\/div>\n
Eight essentials:<\/div>\n
Team-based care, accurate BP measurement, prompt treatment, patient engagement, HBPM review, adherence checks, monthly visits until control, telehealth\/EHR integration.<\/div>\n
<\/div>\n
10.\u2060 \u2060Global Perspective<\/div>\n
\u2022 AHA\/ACC guidelines remain influential despite U.S.-specific resources.<\/span><\/div>\n
\u2022 ISH emphasizes the need for practical, adaptable frameworks (Essential vs. Optimal recommendations) to improve BP control worldwide.<\/span><\/div>\n
\u2022 Team-based models and standardized BP measurement are universally critical.<\/span><\/div>\n
<\/div>\n
\u00a0https:\/\/ish-world.com\/document\/1764854170.pdf<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Multisociety Hypertension Guidelines (Messages to the World) Source: Hypertension News \u2013 December 2025 Keynotes : \u20071.\u2060 \u2060Broad, Multidisciplinary U.S. Effort \u2022 Guideline developed with 11 U.S. societies (cardiology, nephrology, geriatrics, neurology, pharmacy, nursing, general practice). \u2022 Reflects a team-based, population-level strategy for a country where >45% of adults meet hypertension criteria. \u20072.\u2060 \u2060Blood Pressure Measurement […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9326","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9326"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9326\/revisions"}],"predecessor-version":[{"id":9327,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9326\/revisions\/9327"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}